Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PARP1 | P09874 | 10/20 | 0.51 |
| ▸ | PARP2 | Q9UGN5 | 2/20 | 0.39 |
| ▸ | CDC7 | O00311 | 1/20 | 0.37 |
| ▸ | PIM1 | P11309 | 1/20 | 0.37 |
| ▸ | CSNK2B | P67870 | 1/20 | 0.37 |
| ▸ | CSNK2A1 | P68400 | 1/20 | 0.37 |
| ▸ | ERCC1 | P07992 | 1/20 | 0.37 |
| ▸ | ERCC4 | Q92889 | 1/20 | 0.37 |
| ▸ | MLLT1 | Q03111 | 2/20 | 0.35 |
| ▸ | AKT2 | P31751 | 1/20 | 0.34 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.34 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30751356 | 0.79 | PBK (0.40) | PARP1 | |
| SCHEMBL27376324 | 0.75 | CALCA (0.42) | PARP1ALDH1A1 | |
| SCHEMBL31456925 | 0.75 | CALCA (0.42) | PARP1ALDH1A1 | |
| SCHEMBL27376283 | 0.71 | MET (0.47) | MLLT1 | |
| SCHEMBL30751066 | 0.71 | MET (0.47) | MLLT1 | |
| SCHEMBL30751053 | 0.71 | MET (0.47) | MLLT1 | |
| SCHEMBL27376205 | 0.71 | MET (0.47) | MLLT1 | |
| SCHEMBL630294 | 0.67 | PARP1 (1.00) | PARP1PARP2 | |
| SCHEMBL631198 | 0.67 | PARP1 (1.00) | PARP1PARP2 | |
| SCHEMBL30751343 | 0.67 | ADORA1 (0.42) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2024030000-A1 | NOVEL COMPOUND AS HYPOXIA-INDUCIBLE FACTOR 1(HIF-1) INHIBITOR OR VASCULAR ENDOTHELIAL GROWTH FACTOR (VEGF) INHIBITOR, AND PHARMACEUTICAL COMPOSITION COMPRISING SAME | 주식회사 넥스트젠바이오사이언스 | 2024-02-08 | — | — | WO | disclosed |